PA8519601A1 - Compuestos para tratar el desacomodamiento fundico - Google Patents

Compuestos para tratar el desacomodamiento fundico

Info

Publication number
PA8519601A1
PA8519601A1 PA20018519601A PA8519601A PA8519601A1 PA 8519601 A1 PA8519601 A1 PA 8519601A1 PA 20018519601 A PA20018519601 A PA 20018519601A PA 8519601 A PA8519601 A PA 8519601A PA 8519601 A1 PA8519601 A1 PA 8519601A1
Authority
PA
Panama
Prior art keywords
rent
bivalent radical
hydrogen
same
formula
Prior art date
Application number
PA20018519601A
Other languages
English (en)
Spanish (es)
Inventor
Emelen Kristof Van
Bruyn Marcel Frans Leopold De
Manuel Jesus Alcazar-Vaca
Jose Ignacio Andres-Gil
Gad Francisco Javier Fernandez
Bal Maria Encarnacion Matesanz
Jose Manuel Bartolome-Nebreda
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PA8519601A1 publication Critical patent/PA8519601A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D495/00Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
    • C07D495/02Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
    • C07D495/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D411/00Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms
    • C07D411/02Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D411/04Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen and sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/14Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Hydrogenated Pyridines (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PA20018519601A 2000-06-22 2001-06-14 Compuestos para tratar el desacomodamiento fundico PA8519601A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00202180 2000-06-22

Publications (1)

Publication Number Publication Date
PA8519601A1 true PA8519601A1 (es) 2002-08-26

Family

ID=8171674

Family Applications (1)

Application Number Title Priority Date Filing Date
PA20018519601A PA8519601A1 (es) 2000-06-22 2001-06-14 Compuestos para tratar el desacomodamiento fundico

Country Status (34)

Country Link
US (2) US7081453B2 (xx)
EP (1) EP1296987B1 (xx)
JP (1) JP4911860B2 (xx)
KR (1) KR100821107B1 (xx)
CN (2) CN1288157C (xx)
AR (1) AR032158A1 (xx)
AT (1) ATE312104T1 (xx)
AU (1) AU783292B2 (xx)
BG (1) BG65895B1 (xx)
BR (1) BR0111859B1 (xx)
CA (1) CA2410233C (xx)
CZ (1) CZ305005B6 (xx)
DE (1) DE60115647T2 (xx)
EA (1) EA005760B1 (xx)
EE (1) EE04878B1 (xx)
EG (1) EG24462A (xx)
ES (1) ES2254467T3 (xx)
HK (1) HK1057896A1 (xx)
HR (1) HRP20020988B1 (xx)
HU (1) HU227398B1 (xx)
IL (2) IL153559A0 (xx)
IS (1) IS2618B (xx)
JO (1) JO2352B1 (xx)
MX (1) MXPA02012844A (xx)
MY (1) MY155267A (xx)
NO (1) NO328547B1 (xx)
NZ (1) NZ522519A (xx)
PA (1) PA8519601A1 (xx)
PL (1) PL201656B1 (xx)
SA (1) SA01220442B1 (xx)
SK (1) SK287730B6 (xx)
UA (1) UA74576C2 (xx)
WO (1) WO2001098306A1 (xx)
ZA (1) ZA200210303B (xx)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR0011237A (pt) 1999-06-02 2002-03-05 Janssen Pharmaceutica Nv Derivados de benzodioxano, benzofurano ou benzopirano substituìdos com aminoalquila
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus
JO2654B1 (en) * 2000-09-04 2012-06-17 شركة جانسين فارماسوتيكا ان. في Multiple aryl caroxa amides are useful as lipid - lowering agents
JO2409B1 (en) 2000-11-21 2007-06-17 شركة جانسين فارماسوتيكا ان. في Second-phenyl carboxy amides are useful as lipid-lowering agents
RU2379303C2 (ru) 2003-04-24 2010-01-20 Инсайт Корпорейшн Производные азаспироалканов в качестве ингибиторов металлопротеаз
JP4896476B2 (ja) * 2005-09-16 2012-03-14 広栄化学工業株式会社 メチルオキシメチルアミノピリジン誘導体及びその製造方法
US7999107B2 (en) 2007-01-31 2011-08-16 Merck Sharp & Dohme Corp. Substituted pyrano[2,3-B]pyridine derivatives as cannabinoid-1 receptor modulators
CA2685860A1 (en) * 2007-05-10 2008-11-20 Amr Technology, Inc. Aryl- and heteroaryl-substituted tetrahydrobenzo-1,4-diazepines and use thereof to block reuptake of norepinephrine, dopamine, and serotonin
CA2853024C (en) 2011-11-11 2017-08-22 Pfizer Inc. 2-thiopyrimidinones
PE20180503A1 (es) 2015-05-05 2018-03-09 Pfizer 2-tiopirimidinonas
CN105481839B (zh) * 2015-11-23 2018-05-11 安徽千和新材料科技发展有限公司 一种光活性环氧啉对映体的制备方法
EP3229193A1 (en) 2016-04-07 2017-10-11 The Boeing Company A computer-implemented method and system for sharing information between passengers and air traffic management stakeholders

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3910930A (en) 1973-01-04 1975-10-07 Janssen Pharmaceutica Nv 1-{55 1-{8 2-(1,4-Benzodioxan-2-yl)-2-hydroxyethyl{9 -4-piperidyl{56 -2-benzimidazolinones
DE2400049A1 (de) * 1974-01-02 1975-07-10 Spumalit Anstalt Transportkasten aus kunststoff, insbesondere fuer flaschen
GR71865B (xx) 1978-03-20 1983-07-07 Ciba Geigy
US4329348A (en) * 1979-02-26 1982-05-11 Ciba-Geigy Corporation N-Oxacyclic-alkylpiperidines as psychostimulants
DE3484096D1 (de) * 1983-11-30 1991-03-14 Janssen Pharmaceutica Nv Bizyklisches heterozyklyl aufveisende n-(bizyklisches heterozyklyl-4-piperidinamine.
SI9300097B (en) 1992-02-27 2001-12-31 Janssen Pharmaceutica Nv (benzodioxan, benzofuran or benzopyran) alkylamino) alkyl substituted guanidines
ZA931343B (en) 1992-03-06 1993-09-24 Akzo Nv 1,4-dioxino(2,3-b)pyridine derivatives.
US6403103B1 (en) * 1994-08-12 2002-06-11 Bio Merieux Trypanosoma cruzi antigen, gene encoding therefore, and methods of detecting and treating chagas disease
FR2744451B1 (fr) * 1996-02-01 1998-04-24 Pf Medicament Nouvelles imidazolidinones, pyrimidinones, et 1,3-diazepin-2 -ones, leur preparation et leurs applications en therapeutique
US6133277A (en) * 1997-12-05 2000-10-17 Janssen Pharmaceutica N.V. (Benzodioxan, benzofuran or benzopyran) derivatives having fundic relaxation properties
JP2003501428A (ja) 1999-06-02 2003-01-14 ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ ピロリジニル、ピペリジニルもしくはホモピペリジニル置換(ベンゾジオキサン、ベンゾフランもしくはベンゾピラン)誘導体
BR0011237A (pt) 1999-06-02 2002-03-05 Janssen Pharmaceutica Nv Derivados de benzodioxano, benzofurano ou benzopirano substituìdos com aminoalquila
TWI225488B (en) * 1999-12-21 2004-12-21 Janssen Pharmaceutica Nv Derivatives of homopiperidinyl substituted benzimidazole analogues
JO2352B1 (en) * 2000-06-22 2006-12-12 جانسين فارماسيوتيكا ان. في Compounds for the treatment of non-adaptation of the bottom of the uterus

Also Published As

Publication number Publication date
CN1437602A (zh) 2003-08-20
BG65895B1 (bg) 2010-04-30
JO2352B1 (en) 2006-12-12
EE04878B1 (et) 2007-08-15
DE60115647D1 (de) 2006-01-12
ES2254467T3 (es) 2006-06-16
EE200200694A (et) 2004-06-15
SA01220442B1 (ar) 2008-05-21
SK492003A3 (en) 2003-07-01
EP1296987A1 (en) 2003-04-02
BR0111859B1 (pt) 2015-01-06
NO20026219L (no) 2003-02-17
CA2410233C (en) 2011-01-25
AR032158A1 (es) 2003-10-29
US7081453B2 (en) 2006-07-25
JP4911860B2 (ja) 2012-04-04
CN1781921A (zh) 2006-06-07
IL153559A0 (en) 2003-07-06
DE60115647T2 (de) 2006-08-24
BR0111859A (pt) 2003-05-13
EG24462A (en) 2009-07-16
WO2001098306A1 (en) 2001-12-27
SK287730B6 (en) 2011-07-06
EP1296987B1 (en) 2005-12-07
BG107313A (bg) 2003-06-30
HRP20020988A2 (en) 2005-02-28
US20060142318A1 (en) 2006-06-29
IS2618B (is) 2010-04-15
IS6591A (is) 2002-10-25
KR20030007566A (ko) 2003-01-23
HU227398B1 (hu) 2011-05-30
EA200300049A1 (ru) 2003-04-24
AU783292B2 (en) 2005-10-13
HRP20020988B1 (en) 2011-06-30
CA2410233A1 (en) 2001-12-27
IL153559A (en) 2008-03-20
US7423048B2 (en) 2008-09-09
ATE312104T1 (de) 2005-12-15
UA74576C2 (en) 2006-01-16
MY155267A (en) 2015-09-30
JP2004501157A (ja) 2004-01-15
US20040019051A1 (en) 2004-01-29
CN100516066C (zh) 2009-07-22
PL201656B1 (pl) 2009-04-30
CN1288157C (zh) 2006-12-06
CZ2003115A3 (cs) 2003-06-18
NO328547B1 (no) 2010-03-15
AU8386401A (en) 2002-01-02
NO20026219D0 (no) 2002-12-23
EA005760B1 (ru) 2005-06-30
KR100821107B1 (ko) 2008-04-14
CZ305005B6 (cs) 2015-03-25
NZ522519A (en) 2003-09-26
HK1057896A1 (en) 2004-04-23
PL358886A1 (en) 2004-08-23
HUP0301185A3 (en) 2009-03-30
HUP0301185A2 (hu) 2003-08-28
ZA200210303B (en) 2004-03-19
MXPA02012844A (es) 2003-05-15

Similar Documents

Publication Publication Date Title
PA8519601A1 (es) Compuestos para tratar el desacomodamiento fundico
AR088808A2 (es) Derivados de 2h-piridazin-3-ona, composiciones farmaceuticas que los contienen y un proceso para la preparacion de dichos derivados y el uso de dichos derivados para la preparacion de una composicion farmaceutica
GEP20094736B (en) Prodrugs of piperazine and substituted piperidine antiviral agents
AR061008A1 (es) Inhibidores ns5b de vhc de indolobenzazepina fusionados a ciclopropilo
LTPA2016016I1 (lt) Azetinidai kaip mek inhibitoriai, skirti proliferacinių ligų gydymui
PE20081362A1 (es) DERIVADOS MORFOLINO PIRIMIDINA COMO INHIBIDORES DE mTOR QUINASA Y PI3K
ATE450251T1 (de) Liposomale formulierungen mit dihydrosphingomyelin und verfahren zu ihrer verwendung
CY1107074T1 (el) Συνθεση εναντιομερων 4-αμινο-θαλιδομιδης
WO2006100081A3 (de) Substituierte oxindol-derivate, diese enthaltende arzneimittel und deren verwendung
ECSP066383A (es) Derivados de 5-fenil-4-metil-tiazol-2-il-amina como inhibidores de enzimas de cinasa fosfatidilinositol 3 (pi3) para el tratamiento de enfermedades inflamatorias de las vías respiratorias
ATE301653T1 (de) Pyrazolopyridine
AR039672A1 (es) Dipeptido, derivado de benzotiazepina. inhibidor del transporte ileal de acidos biliares (ibat)
NZ592705A (en) 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
PE20212303A1 (es) Inhibidores aza-heterobiciclicos de mat2a y metodos de uso en el tratamiento de cancer
MX2007013624A (es) Inhibidores de proteina cinasa.
CY1109808T1 (el) Αρυλινδενο-πυριδινες και αρυλινδενο-πυριμιδινες και η χρηση τους ως ανταγωνιστων των υποδοχεων αδενοσινης α2α
MX2007007027A (es) Derivados piperazinilpiridina como agentes anti-obesidad.
UA96277C2 (xx) Похідні бензімідазолу$производные бензимидазола
MY121852A (en) 4-(aminoethyl)-piperidine benzamides for treating gastrointestinal disorders
GEP20115201B (en) Cinnamoyl-piperazine derivatives and their use as par- i antagonists
SE0403171D0 (sv) New compounds
UY26564A1 (es) Inhibidores del factor xa con aril - amidinas y sus derivados, y composiciones farmacéuticas que contienen los mismos
UY27980A1 (es) Indoles 2,7-sustituidos
RS94603A (xx) Nova jedinjenja i farmaceutski oblici kao inhibitori katepsina
TW200720262A (en) Novel compounds ii